Preface
Preface on “Emerging treatment options for brain metastases from non-small cell lung cancer”
Translational Lung Cancer Research
2016;
5
(6)
:561-562
.
(29 December 2016)
Review Article
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future
Translational Lung Cancer Research
2016;
5
(6)
:563-578
.
(29 December 2016)
Achievements and future developments of ALK-TKIs in the management of CNS metastases from ALK-positive NSCLC
Translational Lung Cancer Research
2016;
5
(6)
:579-587
.
(29 December 2016)
Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy
Translational Lung Cancer Research
2016;
5
(6)
:588-598
.
(29 December 2016)
State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer
Translational Lung Cancer Research
2016;
5
(6)
:599-609
.
(29 December 2016)
Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer
Translational Lung Cancer Research
2016;
5
(6)
:610-627
.
(29 December 2016)
Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?—current evidence and future perspectives
Translational Lung Cancer Research
2016;
5
(6)
:628-636
.
(29 December 2016)
Defining the endpoints: how to measure the efficacy of drugs that are active against central nervous system metastases
Translational Lung Cancer Research
2016;
5
(6)
:637-646
.
(29 December 2016)
Controversies on Lung Cancer: Pros and Cons (Section Chairs: Suresh Senan, Helmut H. Popper)
Pros: After stereotactic ablative radiotherapy for a peripheral early-stage non-small cell lung cancer, radiological suspicion of a local recurrence can be sufficient indication to proceed to salvage therapy
Translational Lung Cancer Research
2016;
5
(6)
:647-650
.
(29 December 2016)
Cons: After lung stereotactic ablative radiotherapy for a peripheral stage I non-small cell lung carcinoma, radiological suspicion of a local recurrence is not sufficient indication to proceed to salvage therapy
Translational Lung Cancer Research
2016;
5
(6)
:651-654
.
(29 December 2016)
Rebuttal from Dr. Nguyen and Dr. Palma
Translational Lung Cancer Research
2016;
5
(6)
:655-657
.
(29 December 2016)
Rebuttal from Dr. Bezjak and Dr. Giuliani
Translational Lung Cancer Research
2016;
5
(6)
:658-659
.
(29 December 2016)
Editorial
ASCEND-2: a canary in a coal mine for descending to second-line treatment for ALK-rearranged non-small cell lung cancer
Translational Lung Cancer Research
2016;
5
(6)
:660-664
.
(29 December 2016)
Original Article
Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing
Translational Lung Cancer Research
2016;
5
(6)
:665-672
.
(29 December 2016)
Impact of dose calculation models on radiotherapy outcomes and quality adjusted life years for lung cancer treatment: do we need to measure radiotherapy outcomes to tune the radiobiological parameters of a normal tissue complication probability model?
Translational Lung Cancer Research
2016;
5
(6)
:673-680
.
(29 December 2016)
Statistic and dosimetric criteria to assess the shift of the prescribed dose for lung radiotherapy plans when integrating point kernel models in medical physics: are we ready?
Translational Lung Cancer Research
2016;
5
(6)
:681-687
.
(29 December 2016)
Statistical control process to compare and rank treatment plans in radiation oncology: impact of heterogeneity correction on treatment planning in lung cancer
Translational Lung Cancer Research
2016;
5
(6)
:688-694
.
(29 December 2016)
Review Article
Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance
Translational Lung Cancer Research
2016;
5
(6)
:695-708
.
(29 December 2016)
Case Report
A rare case of palatin tonsillar metastasis from small cell lung cancer
Translational Lung Cancer Research
2016;
5
(6)
:709-711
.
(29 December 2016)
Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literature
Translational Lung Cancer Research
2016;
5
(6)
:712-719
.
(29 December 2016)
Metastatic lymphoepithelioma-like carcinoma of the lung treated with nivolumab: a case report and focused review of literature
Translational Lung Cancer Research
2016;
5
(6)
:720-726
.
(29 December 2016)
Perspective
Metastatic lung cancer in the age of targeted therapy: improving long-term survival
Translational Lung Cancer Research
2016;
5
(6)
:727-730
.
(29 December 2016)
Disclosure:
The focused issue “Emerging Treatment Options for Brain Metastases from Non-small Cell Lung Cancer” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Giulio Metro and Rita Chiari served as the unpaid Guest Editors for the focused issue.
